Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-31

FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Fluocinonide Acetonide Oil from Rising Pharma Holdings, Inc., a topical corticosteroid product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluocinonide Acetonide Oil (Fluocinonide acetonide)

Snippet

SUPPL AP for FLUOCINOLONE ACETONIDE OIL (FLUOCINOLONE ACETONIDE)